2023 M&A Selected Deal Highlights
As part of our 2023 Deal Rewind, see below for certain key M&A deals led by our US team in the second half of 2023.
- ICON plc, a world-leading healthcare intelligence and clinical research organization, in its acquisition of Biotel Research LLC (formerly known as Philips Pharma Solutions), a leading provider of medical imaging and cardiac safety monitoring services.
- Danaher Ventures LLC, the corporate venture subsidiary of Danaher Corporation, in its investment in BlueWhale Bio, Inc., a new company spun out of the University of Pennsylvania to overcome key bottlenecks in cell and gene therapy manufacturing.
- Mark Edward Partners, a provider of property and casualty and life and health products and services to corporations, high-net-worth individuals and families and non-profit organizations worldwide, in its sale to ALKEME, a top 40 insurance broker.